Kleeff J, Korc M, Apte M, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022.

Article  PubMed  Google Scholar 

Siegel RL, Giaquinto JA. Cancer statistics. CA Cancer J Clin. 2024;2024(74):12–49.

Article  Google Scholar 

Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–21.

Article  CAS  PubMed  Google Scholar 

Strobel O, Neoptolemos J, Jager D, et al. Optimizing the outcomes of pancreatic cancer surgery. Nat Rev Clin Oncol. 2019;16:11–26.

Article  CAS  PubMed  Google Scholar 

Hartwig W, Hackert T, Hinz U, et al. Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg. 2011;254:311–9.

Article  PubMed  Google Scholar 

Hank T, Strobel O. Conversion Surgery for Advanced Pancreatic Cancer. J Clin Med. 2019;8:1945.

Janssen QP, Buettner S, Suker M, et al. Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis. J Natl Cancer Inst. 2019;111:782–94.

Article  PubMed  PubMed Central  Google Scholar 

Neoptolemos JP, Palmer DH, Ghaneh P, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389:1011–24.

Article  CAS  PubMed  Google Scholar 

Conroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med. 2018;379:2395–406.

Article  CAS  PubMed  Google Scholar 

Strobel O, Lorenz P, Hinz U, et al. Actual Five-year Survival After Upfront Resection for Pancreatic Ductal Adenocarcinoma: Who Beats the Odds? Ann Surg. 2022;275:962–71.

Article  PubMed  Google Scholar 

Hackert T, Sachsenmaier M, Hinz U, et al. Locally Advanced Pancreatic Cancer: Neoadjuvant Therapy With Folfirinox Results in Resectability in 60% of the Patients. Ann Surg. 2016;264:457–63.

Article  PubMed  Google Scholar 

Klaiber U, Schnaidt ES, Hinz U, et al. Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer. Ann Surg. 2021;273:154–62.

Article  PubMed  Google Scholar 

Suker M, Beumer BR, Sadot E, et al. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol. 2016;17:801–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hank T, Sandini M, Ferrone CR, et al. A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer: The PANAMA-score. Ann Surg. 2022;275:391–7.

Article  PubMed  Google Scholar 

Bockhorn M, Uzunoglu FG, Adham M, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014;155:977–88.

Article  PubMed  Google Scholar 

Callery MP, Chang KJ, Fishman EK, et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009;16:1727–33.

Article  PubMed  Google Scholar 

Tempero MA, Malafa MP, Al-Hawary M, et al. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017;15:1028–61.

Article  PubMed  Google Scholar 

Isaji S, Mizuno S, Windsor JA, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma. Pancreatology. 2017;2018(18):2–11.

Google Scholar 

Springfeld C, Ferrone CR, Katz MHG, et al. Neoadjuvant therapy for pancreatic cancer. Nat Rev Clin Oncol. 2023;20:318–37.

Article  PubMed  Google Scholar 

Ghaneh P, Palmer D, Cicconi S, et al. Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2023;8:157–68.

Article  PubMed  Google Scholar 

Versteijne E, van Dam JL, Suker M, et al. Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial. J Clin Oncol. 2022;40:1220–30.

Article  CAS  PubMed  Google Scholar 

van Dam JL, Janssen QP, Besselink MG, et al. Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials. Eur J Cancer. 2022;160:140–9.

Article  PubMed  Google Scholar 

Labori KJ, Bratlie SO, Andersson B, et al. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol.9(3):205–17.

Schneider M, Hackert T, Strobel O, et al. Technical advances in surgery for pancreatic cancer. Br J Surg. 2021;108:777–85.

Article  CAS  PubMed  Google Scholar 

Weitz J, Rahbari N, Koch M, et al. The “artery first” approach for resection of pancreatic head cancer. J Am Coll Surg. 2010;210:e1–4.

Article  PubMed  Google Scholar 

Sanjay P, Takaori K, Govil S. et al. ‘Artery-first’ approaches to pancreatoduodenectomy. Br J Surg. 2012;99:1027–35.

Article  CAS  PubMed  Google Scholar 

Ironside N, Barreto SG, Loveday B, et al. Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival. Br J Surg. 2018;105:628–36.

Article  CAS  PubMed  Google Scholar 

Hackert T, Werner J, Weitz J, et al. Uncinate process first—a novel approach for pancreatic head resection. Langenbecks Arch Surg. 2010;395:1161–4.

Article  PubMed  Google Scholar 

Inoue Y, Saiura A, Yoshioka R, et al. Pancreatoduodenectomy With Systematic Mesopancreas Dissection Using a Supracolic Anterior Artery-first Approach. Ann Surg. 2015;262:1092–101.

Article  PubMed  Google Scholar 

Adham M, Singhirunnusorn J. Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors. Eur J Surg Oncol. 2012;38:340–5.

Article  CAS  PubMed  Google Scholar 

Hackert T, Strobel O, Michalski CW, et al. The TRIANGLE operation—radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study. Hpb (oxford). 2017;19:1001–7.

Article  PubMed  Google Scholar 

Klotz R, Hackert T, Heger P, et al. The TRIANGLE operation for pancreatic head and body cancers: early postoperative outcomes. Hpb (oxford). 2022;24:332–41.

Article  PubMed  Google Scholar 

Strasberg SM, Drebin JA, Linehan D. Radical antegrade modular pancreatosplenectomy. Surgery. 2003;133:521–7.

Article  PubMed  Google Scholar 

Sivasanker M, Desouza A, Bhandare M, et al. Radical antegrade modular pancreatosplenectomy for all pancreatic body and tail tumors: rationale and results. Langenbecks Arch Surg. 2019;404:183–90.

Article  PubMed  Google Scholar 

Klompmaker S, van Hilst J, Gerritsen SL, et al. Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Ann Surg Oncol. 2018;25:1440–7.

Article  PubMed  PubMed Central  Google Scholar 

Klompmaker S, Peters NA, van Hilst J, et al. Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis. Ann Surg Oncol. 2019;26:772–81.

Article  PubMed  PubMed Central  Google Scholar 

Nagakawa Y, Jang JY, Kawai M, et al. Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study. Ann Surg. 2021.

Google Scholar 

Murakami Y, Satoi S, Motoi F, et al. Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma. Br J Surg. 2015;102:837–46.

Article  CAS  PubMed  Google Scholar 

Schmidt T, Strobel O, Schneider M, et al. Cavernous transformation of the portal vein in pancreatic cancer surgery-venous bypass graft first. Langenbecks Arch Surg. 2020;405:1045–50.

Article  PubMed  PubMed Central  Google Scholar 

Hackert T, Klaiber U, Hinz U, et al. Portal Vein Resection in Pancreatic Cancer Surgery: Risk of Thrombosis and Radicality Determine Survival. Ann Surg. 2022;.

Strasberg SM, Bhalla S, Sanchez LA, et al. Pattern of venous collateral development after splenic vein occlusion in an extended Whipple procedure : comparison with collateral vein pattern in cases of sinistral portal hypertension. J Gastrointest Surg. 2011;15:2070–9.

Article  PubMed  Google Scholar 

Loos M, Mehrabi A, Ramouz A, et al. Gastric Venous Congestion After Total Pancreatectomy is Frequent and Dangerous. Ann Surg. 2022;276:e896–e904.

Article  PubMed  Google Scholar 

Al-Saeedi M, Frank-Moldzio L, Contin P, et al. Splenorenal shunt for reconstruction of the gastric and splenic venous drainage during pancreatoduodenectomy with resection of the portal venous confluence. Langenbecks Arch Surg. 2021;406:2535–43.

Article